Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic

BACKGROUND: The outbreak of COVID19 evolved rapidly into a global pandemic, forcing hospitals, including inflammatory bowel disease (IBD) referral units, to change their practices to ensure quality of care. AIMS: To describe the clinical outcomes and the fulfilment of the treatment schedule of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Iborra, Ignacio, Puig, Maria, Marín, Laura, Calafat, Margalida, Cañete, Fiorella, Quiñones, Carles, González-González, Laura, Cardona, Glòria, Mañosa, Míriam, Domènech, Eugeni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814978/
https://www.ncbi.nlm.nih.gov/pubmed/33469807
http://dx.doi.org/10.1007/s10620-020-06807-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814978/
https://www.ncbi.nlm.nih.gov/pubmed/33469807
http://dx.doi.org/10.1007/s10620-020-06807-0

Ejemplares similares